Skip to main content
. 2019 Apr 6;12(3):317–324. doi: 10.21053/ceo.2018.01613

Table 2.

Detailed characteristics of the patients

Variable All subjects Male Female P-value
No. of subjects 159 85 74 -
Age (yr) 62.2±12.1 (19–86) 62.2±10.1 (37–83) 62.3±14.2 (19–86) 0.661*
Weight (kg) 72±11.1 (39–99) 71.9±15.8 (45–109) 67.4±13.3 (38–98) 0.051
Height (cm) 165.3±8.3 (148–190) 170.1±6.8 (154–190) 159.9±7.5 (148–175) <0.001
Body mass index (kg/m2) 25.6±5.7 (15.9–44.8) 24.9±5.7 (15.9–44.8) 26.4±5.5 (16.7–41.4) 0.091
Stage 0.004
 0 7 (4.4) 1 (1.2) 6 (8.1)
 1 69 (43.4) 30 (35.3) 39 (52.7)
 2 43 (27) 29 (34.1) 14 (18.9)
 3 35 (22) 21 (24.7) 14 (18.9)
 4 5 (3.2) 4 (4.7) 1 (1.4)
Performance status 0.859
 0 31 (19.5) 16 (18.8) 15 (20.3)
 1 35 (22) 18 (21.2) 17 (23)
 2 51 (32.1) 32 (37.7) 19 (25.7)
 3 37 (23.3) 16 (18.8) 21 (28.3)
 4 5 (3.2) 3 (3.5) 2 (2.7)
Sarcopenia 0.021
 Yes 80 (50.3) 50 (59.5) 30 (40)
 No 79 (48.7) 34 (40.5) 45 (60)
Location of HNC <0.001
 Nasopharynx 60 (37.7) 51 (60) 9 (12.2)
 Oral cavity 4 (2.5) 4 (4.7) -
 Hypopharynx 32 (20.1) 8 (9.4) 24 (32.4)
 Oropharynx 34 (21.4) 6 (7.1) 28 (37.8)
 Larynx 29 (18.2) 16 (18.8) 13 (17.6)

Values are presented as mean±standard deviation (range) or number (%).

HNC, head and neck cancer.

*

Nonparametric test was used.